Meningococcal disease and polymorphism of FcγRIIa (CD32) in late complement component-deficient individuals

Clinical and Experimental Immunology

Volumn 111, Issue 1, 1998, Pages 97-101

  Platonov, A E ^c   Kuijper, E J ^a   Vershinina, I V ^c   Shipulin, G A ^c   Westerdaal, N ^b   Fijen, C A P ^a   Van De Winkel, J G J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Central Research Institute of Epidemiology   (Russian Federation)

Author keywords

Complement; Deficiency; Fc RIIa; Infection; Meningococcal

Indexed keywords

CD32 ANTIGEN;

ADOLESCENT; ADULT; ALLOTYPE; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT DEFICIENCY; DISEASE COURSE; FEMALE; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFECTION SENSITIVITY; MALE; MENINGOCOCCOSIS; PHAGOCYTOSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; INFANT; MALE; MENINGOCOCCAL INFECTIONS; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 0031930501     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00484.x     Document Type: Article

References (30)

1. Esser AE. The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicol 1994; 87:229-47.
2. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microhiol Rev 1991; 4:359-95.
3. Platonov AE, Beloborodov VB, Vershinina IV. Meningococcal disease in patients with late complement components deficiency: studies in the USSR. Med (Baltimore) 1993; 72:374-92.
4. Andreoni J, Käyhty H, Densen P. Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals. J Infect Dis 1993; 168:227-31.
5. Lowell GH, Smith LH, Griffiss JM, Brandt BL, MacDermott RP. Antibody-dependent mononuclear cell mediated antimeningococcal activity. Comparison on the effects of convalescent and postimmunization immunoglobulins G, M, and A. J Clin Invest 1980; 66:260-7.
6. Platonov AE, Vershinina IV, Dankert J, Kuijper EJ, Gustafson L, Käyhty H. Long-term follow-up of late complement component deficient patients vaccinated with meningococcal polysaccharide vaccine: antibody persistence and efficacy of vaccination. In: Zollinger WD et al., eds. Pathogenic Neisseria 1996:235-6.
7. Bredius RGM, Derkx BHF, Fijen CAP et al. Fcγ receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994; 170:848-53.
8. van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity: molecular and clinical implications. Immunol Today 1993; 14:215-21.
9. Parren PWHI, Warmerdam PAM, Boeije LCM et al. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest 1992; 90:1537-46.
10. van Warmerdam PAM, de Winkel JGJ, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second IgG-like domain of the human Fcγ receptor II is critical for human IgG2 binding. J Immunol 1991; 147:1338-43.
11. Saucedo L, Ackermann L, Platonov AE, Gewurz A, Rakita R, Densen P. Delineation of additional genetic bases for C8 beta deficiency: prevalence of null alleles and predominance of C-T exchange in their genesis. J Immunol 1995; 155:5022-8.
12. Würzner R, Platonov AE, Beloborodov VB et al. How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 level following plasma transfusion. Immunol 1996; 88:407-11.
13. Platonov AE, Beloborodov VB, Gabrilovitch DI, Khabarova VV, Serebrovskaya LV. Immunological evaluation of late complement component-deficient individuals. Clin Immunol Immunopathol 1992; 64:98-105.
14. Platonov AE, Beloborodov VB, Pavlova LI, Vershinina IV, Käyhty H. Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 1995; 100:32-39.
15. Platonov AE, Koroleva IS, Shipulin GA, Shipulina OJ, Vershinina IV, Dankert J. Comparison of different methods to diagnose bacterial meningitis in Russia. In: Zollinger WD, Frasch CE, Deal CD, eds. Pathogenic Neisseria, 1996:515-6.
16. Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev 1992; 5:130-45.
17. Brandtzaeg P. Pathogenesis of meningococcal infections. In: Cartwright K, ed. Meningococcal disease. Chichester: Wiley & Sons, 1995:71-114.
18. Martin MA, Silverman HJ. Gram-negative sepsis and the adult respiratory distress syndrome. Clin Infect Dis 1992; 4:1213-28.
19. Boom R, Sol CJA, Salimans MMM et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28:495-503.
20. Osborne JM, Chacko GW, Brandt JT, Anderson CL. Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele-specific oligonucleotide probes. J Immunol Methods 1994; 173:207-17.
21. Cartwright K. Meningococcal carriage and disease. In: Cartwright K. ed. Meningococcal disease. Chichester: Wiley & Sons, 1995:115-46.
22. Noah N, Connolly M. Surveillance of bacterial meningitis in Europe 1995. London: King's College School of Medicine & Dentistry, 1996.
23. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of human antibodies. J Exp Med 1969; 129:1307-26.
24. Ferrante A, Beard LJ, Feldman RG. IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatr Infect Dis J 1990; 9:S16-S24.
25. Fijen CAP, Bredius RGM, Kuijper EJ. Polymorphism of IgG Fc receptors in meningococcal disease: risk marker in complement deficient patients. Ann Intern Med 1993; 119:636.
26. Sanders LAM, Feldman RG, Voorhorst-Ogink MM et al. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 1995; 63:73-81.
27. Platonov AE, Vershinina IV, Dolgopolova AJ, Dankert J, Fijen CAP, Käyhty H. Bactericidal effect of human neutrophils on meningococci incubated in pre- and post-vaccination serum of complement deficient patients. In: Zollinger WD et al., eds. Pathogenic Neisseria, 1996:178-9.
28. Jones SL, Brown EJ. Functional cooperation between Fcγ receptors and complement receptors in phagocytes. In: van de Winkel JGJ, Capel PJA, eds. Human IgG Fc receptors. Austin, Texas: RG Landes Co., 1996:149-63.
29. Fijen K. Meningococcal disease and complement deficiency in the Netherlands. Thesis. Amsterdam: University of Amsterdam, 1995.
30. Drogari-Apiranthitou M, Fijen CAP, Dankert J, Kuijper EJ. Effect of vaccination on phagocytic killing of meningococci in individuals with late complement component deficiency. Exp Clin Immunogenet 1997; 14:46.